{"product_id":"biomarkers-in-drug-discovery-and-development-9781119187509","title":"Biomarkers in Drug Discovery and Development","description":"\u003cp\u003eThis book continues the legacy of a well-established reference within the pharmaceutical industry - providing perspective, covering recent developments in technologies that have enabled the expanded use of biomarkers, and discussing biomarker characterization and validation and applications throughout drug discovery and development.\u003c\/p\u003e \u003cul\u003e \u003cli\u003eExplains where proper use of biomarkers can substantively impact drug development timelines and costs, enable selection of better compounds and reduce late stage attrition, and facilitate personalized medicine\u003c\/li\u003e \u003cli\u003eHelps readers get a better understanding of biomarkers and how to use them, for example which are accepted by regulators and which still non-validated and exploratory\u003c\/li\u003e \u003cli\u003eUpdates developments in genomic sequencing, and application of large data sets into pre-clinical and clinical testing; and adds new material on data mining, economics, and decision making, personal genetic tools, and wearable monitoring\u003c\/li\u003e \u003cli\u003eIncludes case studies of biomarkers that have helped and hindered decision making\u003c\/li\u003e \u003cli\u003eReviews of the first edition: \u003cbr\u003e\"If you are interested in biomarkers, and it is difficult to imagine anyone reading this who wouldn't be, then this book is for you.\" (\u003ci\u003eISSX\u003c\/i\u003e) and \"...provides a good introduction for those new to the area, and yet it can also serve as a detailed reference manual for those practically involved in biomarker implementation.\" (\u003ci\u003eChemMedChem\u003c\/i\u003e)\u003c\/li\u003e \u003c\/ul\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eAuthor:\u003c\/b\u003e Ramin Rahbari\u003cbr\u003e\u003cb\u003ePublisher:\u003c\/b\u003e Wiley\u003cbr\u003e\u003cb\u003ePublished:\u003c\/b\u003e 03\/06\/2020\u003cbr\u003e\u003cb\u003ePages:\u003c\/b\u003e 608\u003cbr\u003e\u003cb\u003eBinding Type:\u003c\/b\u003e Hardcover\u003cbr\u003e\u003cb\u003eWeight:\u003c\/b\u003e 1.90lbs\u003cbr\u003e\u003cb\u003eSize:\u003c\/b\u003e 9.10h x 6.00w x 1.10d\u003cbr\u003e\u003cb\u003eISBN:\u003c\/b\u003e 9781119187509\u003cbr\u003e\u003cp\u003e\u003cb\u003eAbout the Author\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003e\u003cb\u003eRAMIN RAHBARI, MS, MBA, \u003c\/b\u003e is an expert in biomarkers at Innovative Scientific Management and has previously held similar consulting and research positions at IBM, Cognizant and Pfizer. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eJONATHAN VAN NIEWAAL, MBA, \u003c\/b\u003e is Technology Principal at Innovative Scientific Management and has held software development and technology delivery roles in the healthcare, financial services, and technology industries. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eMICHAEL R. BLEAVINS, PHD, DABT, \u003c\/b\u003e is the founder of White Crow Innovation, LLC, a Michigan-based drug development consulting company, and cofounder of Michigan Technology and Research Institute.\u003cbr\u003e\u003c\/p\u003e\u003cp\u003e\u003ci\u003eThis title is not returnable\u003c\/i\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Wiley","offers":[{"title":"Hardcover","offer_id":40689479680115,"sku":"9.78112E+12","price":336.95,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0555\/9255\/0515\/products\/img_3842c7a7-e8c1-451f-bfee-913d04a56ea4.jpg?v=1675266541","url":"https:\/\/bookstorenmore.com\/en-de\/products\/biomarkers-in-drug-discovery-and-development-9781119187509","provider":"Bookstore N More","version":"1.0","type":"link"}